+
India To Set Up CRISPR Innovation Centre In Bengaluru
Technology

India To Set Up CRISPR Innovation Centre In Bengaluru

A new Letter of Intent has been signed to establish a Centre of Excellence for CRISPR Innovation and Translation, aimed at harnessing advanced CRISPR technologies to convert laboratory research into real-world clinical applications. The proposed centre will act as a dedicated hub to accelerate the translation of scientific discoveries into affordable and scalable healthcare solutions.

The Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru—an autonomous institute under the Department of Science and Technology—and Delhi-based CrisprBits Private Limited have jointly announced the initiative, marking one of India’s early public–private partnerships in CRISPR-based biotechnology. CrisprBits specialises in gene-editing platforms focused on developing cost-effective diagnostic and therapeutic solutions.

The Centre of Excellence is envisioned as a bridge between fundamental research and clinical impact, combining JNCASR’s strengths in biomedical sciences with CrisprBits’ expertise in applied gene-editing and translational technologies. By addressing the long-standing gap between laboratory innovation and bedside application, the centre aims to demonstrate how Indian scientific research can be effectively transformed into societal and clinical benefits. It is also expected to serve as a replicable national model for strengthening collaboration between academia and industry within India’s biotechnology ecosystem.

Commenting on the development, JNCASR President Umesh Waghmare said the partnership represents a landmark step for the institution, bringing together complementary capabilities in genetics, molecular and chemical biology, and computational biology. He added that the collaboration would open new pathways to deliver societal impact while contributing to national scientific and innovation missions.

A new Letter of Intent has been signed to establish a Centre of Excellence for CRISPR Innovation and Translation, aimed at harnessing advanced CRISPR technologies to convert laboratory research into real-world clinical applications. The proposed centre will act as a dedicated hub to accelerate the translation of scientific discoveries into affordable and scalable healthcare solutions. The Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru—an autonomous institute under the Department of Science and Technology—and Delhi-based CrisprBits Private Limited have jointly announced the initiative, marking one of India’s early public–private partnerships in CRISPR-based biotechnology. CrisprBits specialises in gene-editing platforms focused on developing cost-effective diagnostic and therapeutic solutions. The Centre of Excellence is envisioned as a bridge between fundamental research and clinical impact, combining JNCASR’s strengths in biomedical sciences with CrisprBits’ expertise in applied gene-editing and translational technologies. By addressing the long-standing gap between laboratory innovation and bedside application, the centre aims to demonstrate how Indian scientific research can be effectively transformed into societal and clinical benefits. It is also expected to serve as a replicable national model for strengthening collaboration between academia and industry within India’s biotechnology ecosystem. Commenting on the development, JNCASR President Umesh Waghmare said the partnership represents a landmark step for the institution, bringing together complementary capabilities in genetics, molecular and chemical biology, and computational biology. He added that the collaboration would open new pathways to deliver societal impact while contributing to national scientific and innovation missions.

Next Story
Infrastructure Energy

BMW Industries partners with IOCL for PNG supply at Bokaro plant

BMW Industries has entered into a strategic partnership with Indian Oil Corporation (IOCL) for the supply of Piped Natural Gas (PNG), reinforcing its commitment to adopting cleaner and more efficient energy sources for its operations.The agreement was signed at the Eastern Region Pipelines (ERPL) headquarters in Kolkata. The partnership is expected to support the company’s upcoming manufacturing facility in Bokaro by facilitating the use of natural gas as a primary energy source.According to the company, the adoption of PNG will help enhance operational efficiency while also contributing to ..

Next Story
Real Estate

Bombay Realty Secures RERA for Three ICC Tower in South Mumbai

Bombay Realty, the real estate arm of Bombay Dyeing and part of the Wadia Group, has received Real Estate Regulatory Authority (RERA) certification for Three ICC – Wing A, the latest luxury residential tower at Island City Center in Mumbai’s Dadar.The RERA registration marks a key milestone in the development timeline and reinforces the company’s focus on regulatory transparency, timely project delivery, and high construction standards.Following the success of One ICC and Two ICC, the upcoming Three ICC tower represents the next phase of the Island City Center development. The project ai..

Next Story
Infrastructure Energy

Flender launches India’s largest wind gearbox test rig in Walajabad

Flender has inaugurated a 13.5 MW wind turbine gearbox test rig at its Walajabad facility near Chennai, marking the largest installation of its kind in India. The new facility is expected to strengthen the company’s manufacturing and testing capabilities while supporting the growing demands of the wind power sector in both domestic and global markets.The test rig was inaugurated on March 5 in the presence of Andreas Evertz, Group CEO, Flender; Lars Wiegemann, Vice President Wind Gears, Flender; and Vinod Shetty, CEO, Flender India, along with key industry customers and stakeholders.The insta..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement